UK markets open in 5 hours 33 minutes

InnoCare Pharma Ltd (33C.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.5900-0.0100 (-1.67%)
At close: 09:59AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
738,537
738,537
625,404
1,043,033
1,364
Cost of revenue
128,435
128,435
143,397
65,667
0
Gross profit
610,102
610,102
482,007
977,366
1,364
Operating expenses
Research development
751,176
751,176
639,139
721,584
402,771
Selling general and administrative
252,126
252,126
309,549
343,268
113,149
Total operating expenses
1,259,815
1,259,815
1,213,147
1,143,605
495,911
Operating income or loss
-649,713
-649,713
-731,140
-166,239
-494,547
Interest expense
35,031
35,031
17,045
2,642
1,139
Income before tax
-644,206
-644,206
-893,727
-20,121
-391,865
Income tax expense
1,426
1,426
0
46,558
0
Income from continuing operations
-645,632
-645,632
-893,727
-66,679
-391,865
Net income
-631,263
-631,263
-886,593
-64,545
-391,395
Net income available to common shareholders
-631,263
-631,263
-886,593
-64,545
-391,395
Basic EPS
-0.32
-0.37
-0.60
-0.05
-0.40
Diluted EPS
-0.32
-0.37
-0.60
-0.05
-0.40
Basic average shares
1,704,282
1,687,470
1,479,565
1,366,261
967,576
Diluted average shares
1,704,282
1,687,470
1,479,565
1,366,261
967,576